In May 2026, an international team of scientists published the results of a large-scale study involving over 500,000 participants across Europe, Asia, and North America, revealing that daily consumption of two to three cups of coffee was linked to a 35 percent reduction in the risk of dementia.
Data analysis spanning a ten-year period showed that this protective effect persists regardless of the coffee variety or preparation method, as the primary benefits are driven by antioxidants and caffeine, which improve cerebral blood flow and reduce neuroinflammation.
One unexpected finding was the absence of significant differences between espresso lovers and instant coffee drinkers, a result that challenges previous assumptions about the supposed superiority of whole-bean coffee.
Researchers also examined the participants' motivations, noting that regular coffee consumption is frequently paired with social rituals that provide additional stress relief and support cognitive health.
Looking back today, these 2026 findings remain highly relevant, although subsequent meta-analyses have clarified that the maximum benefit is achieved through moderate consumption without added sugar and when combined with regular physical activity.
Ultimately, the discovery underscores the potential of simple dietary habits in the prevention of neurodegenerative diseases, which affect millions of people across the globe.
